Medistim ASA (MEDI)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 281.00 |
|---|---|
| 52-week range | 186.50 – 292.00 |
| Return, 1 month / 3 months | +12.0% / +24.9% |
| Return, 1 year / 3 years | +20.8% / +67.4% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 35.6% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 4.31M NOK |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medistim ASA is a Norwegian medical technology company that develops and supplies equipment for measuring blood flow during surgery. Its products include transit-time flow measurement systems and ultrasound imaging probes used by cardiac and vascular surgeons to check that vessels and bypass grafts are working properly during operations. The company serves hospitals and surgical teams, and its devices are used in operating rooms for procedures on the heart and blood vessels. Medistim is based in Oslo, Norway.
Medistim ASA trades under the code MEDI on the Oslo Stock Exchange in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medistim ASA (MEDI) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 281.00 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 82 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 20.8% and over the last three months it rose 24.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.2% | ||
| From 52-week high | -2.1% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.9% | ||
| 6-month return | 26.1% | ||
| 12-month return, skipping the last month | 7.9% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.31M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +12.0% |
| 3 months | +24.9% |
| 6 months | +26.1% |
| 1 year | +20.8% |
| 3 years | +67.4% |
| 5 years | −11.3% |
Signals
| 50-day / 200-day average | 256.84 / 229.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | NOK 8.0000 |
| 9 May 2025 | NOK 6.0000 |
| 25 Apr 2024 | NOK 4.5000 |
| 25 Apr 2023 | NOK 4.5000 |
| 28 Apr 2022 | NOK 3.7500 |
| 28 Apr 2021 | NOK 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.